Clinical Trials Browser

Phase 2 × Human Papillomavirus Recombinant Vaccine nonavalent × 30 days × Clear all

NCT03036930 2026-05-29

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Phase 2 Active not recruiting

51 enrolled 10 charts

Papillomavirus Infections